Literature DB >> 20354168

AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species.

Marisa M Juntilla1, Vineet D Patil, Marco Calamito, Rohan P Joshi, Morris J Birnbaum, Gary A Koretzky.   

Abstract

Although AKT is essential for multiple cellular functions, the role of this kinase family in hematopoietic stem cells (HSCs) is unknown. Thus, we analyzed HSC function in mice deficient in the 2 isoforms most highly expressed in the hematopoietic compartment, AKT1 and AKT2. Although loss of either isoform had only a minimal effect on HSC function, AKT1/2 double-deficient HSCs competed poorly against wild-type cells in the development of myeloid and lymphoid cells in in vivo reconstitution assays. Serial transplantations revealed an essential role for AKT1 and AKT2 in the maintenance of long-term HSCs (LT-HSCs). AKT1/2 double-deficient LT-HSCs were found to persist in the G(0) phase of the cell cycle, suggesting that the long-term functional defects are caused by increased quiescence. Furthermore, we found that the intracellular content of reactive oxygen species (ROS) is dependent on AKT because double-deficient HSCs demonstrate decreased ROS. The importance of maintaining ROS for HSC differentiation was shown by a rescue of the differentiation defect after pharmacologically increasing ROS levels in double-deficient HSCs. These data implicate AKT1 and AKT2 as critical regulators of LT-HSC function and suggest that defective ROS homeostasis may contribute to failed hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20354168      PMCID: PMC2875090          DOI: 10.1182/blood-2009-09-241000

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  52 in total

Review 1.  Stem cells: units of development, units of regeneration, and units in evolution.

Authors:  I L Weissman
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology.

Authors:  D R Plas; S Talapatra; A L Edinger; J C Rathmell; C B Thompson
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

Review 3.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

4.  Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase.

Authors:  K Gottlob; N Majewski; S Kennedy; E Kandel; R B Robey; N Hay
Journal:  Genes Dev       Date:  2001-06-01       Impact factor: 11.361

5.  Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene.

Authors:  W S Chen; P Z Xu; K Gottlob; M L Chen; K Sokol; T Shiyanova; I Roninson; W Weng; R Suzuki; K Tobe; T Kadowaki; N Hay
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

6.  Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice.

Authors:  H Cho; J L Thorvaldsen; Q Chu; F Feng; M J Birnbaum
Journal:  J Biol Chem       Date:  2001-08-31       Impact factor: 5.157

7.  Functional heterogeneity within rhodamine123(lo) Hoechst33342(lo/sp) primitive hemopoietic stem cells revealed by pyronin Y.

Authors:  A Hüttmann; S L Liu; A W Boyd; C L Li
Journal:  Exp Hematol       Date:  2001-09       Impact factor: 3.084

8.  Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta).

Authors:  H Cho; J Mu; J K Kim; J L Thorvaldsen; Q Chu; E B Crenshaw; K H Kaestner; M S Bartolomei; G I Shulman; M J Birnbaum
Journal:  Science       Date:  2001-06-01       Impact factor: 47.728

9.  Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress.

Authors:  Geert J P L Kops; Tobias B Dansen; Paulien E Polderman; Ingrid Saarloos; Karel W A Wirtz; Paul J Coffer; Ting-T Huang; Johannes L Bos; René H Medema; Boudewijn M T Burgering
Journal:  Nature       Date:  2002-09-19       Impact factor: 49.962

10.  Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice.

Authors:  Michael G Kharas; Rachel Okabe; Jared J Ganis; Maricel Gozo; Tulasi Khandan; Mahnaz Paktinat; D Gary Gilliland; Kira Gritsman
Journal:  Blood       Date:  2009-12-14       Impact factor: 22.113

View more
  138 in total

Review 1.  Recent progress in histochemistry and cell biology.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2012-02-25       Impact factor: 4.304

2.  The ATM-BID pathway regulates quiescence and survival of haematopoietic stem cells.

Authors:  Maria Maryanovich; Galia Oberkovitz; Hagit Niv; Lidiya Vorobiyov; Yehudit Zaltsman; Ori Brenner; Tsvee Lapidot; Steffen Jung; Atan Gross
Journal:  Nat Cell Biol       Date:  2012-03-25       Impact factor: 28.824

Review 3.  Fetal Hematopoietic Stem Cells Are the Canaries in the Coal Mine That Portend Later Life Immune Deficiency.

Authors:  Michael D Laiosa; Everett R Tate
Journal:  Endocrinology       Date:  2015-08-04       Impact factor: 4.736

Review 4.  Reactive oxygen species in cancer stem cells.

Authors:  Xiaoke Shi; Yan Zhang; Junheng Zheng; Jingxuan Pan
Journal:  Antioxid Redox Signal       Date:  2012-03-09       Impact factor: 8.401

5.  TLR4-mediated AKT activation is MyD88/TRIF dependent and critical for induction of oxidative phosphorylation and mitochondrial transcription factor A in murine macrophages.

Authors:  Christian P Bauerfeld; Ruchi Rastogi; Gaila Pirockinaite; Icksoo Lee; Maik Hüttemann; Bobby Monks; Morris J Birnbaum; Luigi Franchi; Gabriel Nuñez; Lobelia Samavati
Journal:  J Immunol       Date:  2012-02-06       Impact factor: 5.422

Review 6.  Genetic control of quiescence in hematopoietic stem cells.

Authors:  Takeshi Yamada; Chun Shik Park; H Daniel Lacorazza
Journal:  Cell Cycle       Date:  2013-06-28       Impact factor: 4.534

Review 7.  To breathe or not to breathe: the haematopoietic stem/progenitor cells dilemma.

Authors:  C Piccoli; F Agriesti; R Scrima; F Falzetti; M Di Ianni; N Capitanio
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

Review 8.  Mitophagy in hematopoietic stem cells: the case for exploration.

Authors:  Aashish Joshi; Mondira Kundu
Journal:  Autophagy       Date:  2013-10-11       Impact factor: 16.016

9.  Transient activation of the PI3K-AKT pathway by hepatitis C virus to enhance viral entry.

Authors:  Zhe Liu; Yongjun Tian; Keigo Machida; Michael M C Lai; Guangxiang Luo; Steven K H Foung; Jing-hsiung James Ou
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

Review 10.  DNA damage response, redox status and hematopoiesis.

Authors:  Cary N Weiss; Keisuke Ito
Journal:  Blood Cells Mol Dis       Date:  2013-09-13       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.